Back to Search
JAMES COX, M.D.
M.D.
Dermatology Physician
NPI: 1770723256IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
MD40085(SC)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIFORMED SERVICES UHS FE HEBERT SCHOOL OF MED
Class of 2008
Research & Publications (20)
Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
PMID 19059972·Chest·2008
8-other
Measurement of cytokine release at the single cell level using the ELISPOT assay.
PMID 16473524·Methods·2006
7-preclinical
Tubular heart valves: a new tissue prosthesis design--preclinical evaluation of the 3F aortic bioprosthesis.
PMID 16077422·J Thorac Cardiovasc Surg·2005
8-other
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
PMID 15665646·AIDS Res Hum Retroviruses·2005
4-observational
The role of surgical intervention in the management of atrial fibrillation.
PMID 15562846·Tex Heart Inst J·2004
8-other
Management of unresectable non-small cell carcinoma of the lung (NSCLC).
PMID 14708518·Lung Cancer·2003
8-other
The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
PMID 12952506·Arch Pathol Lab Med·2003
6-review
Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.
PMID 11769958·Biomed Pharmacother·2001
6-review
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
PMID 19577865·Int J Radiat Oncol Biol Phys·2010
3-trial
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
PMID 19515503·Int J Radiat Oncol Biol Phys·2010
8-other
Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study.
PMID 19660879·Int J Radiat Oncol Biol Phys·2010
4-observational
Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808.
PMID 19540055·Int J Radiat Oncol Biol Phys·2010
3-trial
Prevalence of transient hyperphosphatasemia among healthy infants and toddlers.
PMID 19620198·Pediatrics·2009
8-other
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
PMID 19632716·Lancet·2009
3-trial
History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results.
PMID 19651367·J Clin Virol·2009
6-review
INPP5E mutations cause primary cilium signaling defects, ciliary instability and ciliopathies in human and mouse.
PMID 19668215·Nat Genet·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4494 PALMER ROAD NORTH
BETHESDA, MD 20889 - Phone
- (301) 295-2427
Quick Facts
- NPI
- 1770723256
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile